(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetas CAS:866607-35-4

Compositum (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetatum in variis applicationibus pharmaceuticis pollicitationem ostendit. Structura et proprietates eius singulares id candidatum potentialem ad evolutionem medicamentorum faciunt. Speciatim, potentiam in sequentibus campis demonstravit: Investigatio anticancerosa: Studia demonstraverunt hoc compositum effectus inhibitorios in specificas stirpes cellularum cancrarias exhibere, quod potentiam eius ut agens anticancerosum suggerit. Investigationes ulteriores peraguntur ad mechanismum actionis eius et potentialem applicationem in therapia cancraria explorandam. Proprietates Anti-inflammatoriae: Studia prae-clinica indicaverunt (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetatum proprietates anti-inflammatorias habere posse. Hoc studium in investigando potentia eius ad curandas condiciones inflammatorias excitavit. Investigatio Morborum Neurologicorum: Studia initialia suggerunt hoc compositum implicationes pro perturbationibus neurologicis habere posse. Interactiones eius cum specificis viis neuronalibus ulteriorem investigationem in usum eius potentialem in neurologia et psychiatria impulerunt. Systema Administrationis Medicamentorum: Proprietates structurales unicae (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetati eum candidatum ad novos systemata administrationis medicamentorum evolvendos faciunt. Eius facultas alias moleculas includendi et liberandi studium in applicationibus specificis medicamentorum liberandorum excitavit. In conclusione, compositum (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetatum potentialem habet in variis applicationibus pharmaceuticis, a therapia cancri ad systemata liberationis medicamentorum, ita ut sit materia continuae investigationis et progressionis.